Cargando…
The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
CD95/Fas is an apoptosis inducing death receptor. However, it also has multiple nonapoptotic activities that are tumorigenic. Chronic stimulation of CD95 on breast cancer cells can increase their cancer initiating capacity through activation of a type I interferon (IFN-I)/STAT1 pathway when caspases...
Autores principales: | Qadir, Abdul S., Stults, Austin M., Murmann, Andrea E., Peter, Marcus E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987111/ https://www.ncbi.nlm.nih.gov/pubmed/31992798 http://dx.doi.org/10.1038/s41598-020-58211-3 |
Ejemplares similares
-
CD95/Fas ligand mRNA is toxic to cells
por: Putzbach, Will, et al.
Publicado: (2018) -
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
por: Qadir, Abdul S., et al.
Publicado: (2021) -
The role of CD95 and CD95 ligand in cancer
por: Peter, M E, et al.
Publicado: (2015) -
CD95/Fas promotes tumour growth
por: Chen, Lina, et al.
Publicado: (2010) -
Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)